In 2008 was created Renaissance Venture Capital Fund, which is appeared as VC. The leading representative office of defined VC is situated in the Ann Arbor. The venture was found in North America in United States.
The overall number of key employees were 1.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Renaissance Venture Capital Fund, startups are often financed by Arboretum Ventures, eLab Ventures, Wolverine Venture Fund. The meaningful sponsors for the fund in investment in the same round are Frazier Healthcare Partners, Arboretum Ventures, Adams Street Partners. In the next rounds fund is usually obtained by Frazier Healthcare Partners, Arboretum Ventures, Adams Street Partners.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Service Industry. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cirius Therapeutics, Millendo Therapeutics, ArborMetrix. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Funds with similar focus
| Fund Name | Location |
| Advantest | Japan, Tokyo |
| Altien Limited | Chessington, Surrey, United Kingdom |
| BRaVe Media Ventures | New York, New York, United States |
| Eurecan | Navarra, Pamplona, Spain |
| Hash Capital | China, Hong Kong, Kowloon |
| HeidelbergCapital Private Equity | Baden-Wurttemberg, Germany, Heidelberg |
| LINE Financial Corporation | Chiyoda, Japan |
| Listen Ventures | Chicago, Illinois, United States |
| MedFocus Fund | California, Irvine, United States |
| Momiji Bank | Hiroshima, Hiroshima Prefecture, Japan |
| Osaka Innovation Hub | Japan, Osaka, Osaka Prefecture |
| Prophit Investments | - |
| Qihu Zhongcai | - |
| Qingdao Dezhen | China, Japan, Kagoshima Prefecture |
| The Newfoundland and Labrador Association of Technology Industries | Canada, Newfoundland, St. John's |
| Titan Ventures | - |
| Tuscan Ventures | India, Maharashtra, Mumbai |
| VARECO HOLDINGS | - |
| Washington University in St. Louis | Missouri, St Louis, United States |
| WAVE Equity Partners | Boston, Massachusetts, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Strata Oncology | $90M | 28 Jul 2021 | Ann Arbor, Michigan, United States | ||
Autobooks | $25M | 11 Mar 2021 | Detroit, Michigan, United States | ||
Strata Oncology | $26M | 23 May 2018 | Ann Arbor, Michigan, United States | ||
Cirius Therapeutics | $40M | 11 Apr 2017 | Kalamazoo, Michigan, United States | ||
Millendo Therapeutics | $62M | 05 Jan 2016 | Ann Arbor, Michigan, United States | ||
ArborMetrix | $1M | 10 Feb 2014 | Ann Arbor, Michigan, United States | ||
Swift Biosciences | $7M | 17 Oct 2013 | Ann Arbor, Michigan, United States | ||
Fidelis SeniorCare | $20M | 20 May 2013 | Illinois, United States |
– Autobooks from Detroit secures $25m in Series B funding.
– The round was led by MissionOG with participation from Renaissance Venture Capital, Detroit Venture Partners and Draper Triangle, along with TD Bank Group.
– The new investment will be used to expand operations domestically as well as enter international markets, accelerate product innovation and further engage with large, enterprise banks.
– The company intends to use the funds to continue to expand operations domestically, as well as enter international markets, accelerate product innovation, further engage with large, enterprise banks and grow its team.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Strata Oncology | $90M | 28 Jul 2021 | Ann Arbor, Michigan, United States | ||
Autobooks | $25M | 11 Mar 2021 | Detroit, Michigan, United States | ||
Strata Oncology | $26M | 23 May 2018 | Ann Arbor, Michigan, United States | ||
Cirius Therapeutics | $40M | 11 Apr 2017 | Kalamazoo, Michigan, United States | ||
Millendo Therapeutics | $62M | 05 Jan 2016 | Ann Arbor, Michigan, United States | ||
ArborMetrix | $1M | 10 Feb 2014 | Ann Arbor, Michigan, United States | ||
Swift Biosciences | $7M | 17 Oct 2013 | Ann Arbor, Michigan, United States | ||
Fidelis SeniorCare | $20M | 20 May 2013 | Illinois, United States |
